August 15, 2025 · Form 4 insider transaction
Bohnen Shane bought 6,996 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.